Zynerba_Logo-spot_coated_flat_tagline-01.png
Zynerba Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference
February 05, 2019 10:00 ET | Zynerba Pharmaceuticals, Inc.
DEVON, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare...
BIOME-Colour.png
Biome Grow announces supply and production agreement with Province of Newfoundland and Labrador, including distribution and retail services
November 02, 2018 08:30 ET | Biome Grow
Agreement is the largest supply agreement in Atlantic Canada TORONTO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome” or the “Company”) (CSE:BIO) (Frankfurt:6OTA) proudly announces that...
CURE Logo.png
Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical
November 01, 2018 07:25 ET | CURE Pharmaceutical
OXNARD, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has announced that the company secured a $2 million investment...
BIOME-Colour.png
Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
October 18, 2018 07:30 ET | Biome Grow
TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- (CSE: BIO) – Biome Grow (“Biome” or the “Company”) (CSE:BIO) is pleased to announce that the Company’s common shares have been listed on the Frankfurt...
BIOME-Colour.png
Biome Grow is Investing in Atlantic Canadian Cannabis Sector
October 16, 2018 14:41 ET | Biome Grow
TORONTO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome” or the “Company”) is focusing on the Atlantic Canada region and investing in building strong Atlantic Canadian roots ahead of...
Zynerba_Logo-spot_coated_flat_tagline-01.png
Zynerba Pharmaceuticals to Present at the 2018 BIO Investor Forum
October 11, 2018 10:47 ET | Zynerba Pharmaceuticals, Inc.
DEVON, Pa., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare...
BIOME-Colour.png
Biome Grow to begin trading on the Canadian Securities Exchange under the symbol “BIO”
October 09, 2018 07:30 ET | Biome Grow
TORONTO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- (CSE: BIO) – Biome Grow (“Biome” or the “Company”) is pleased to announce that it will begin trading on the Canadian Securities Exchange (“CSE”) at market...
BioSig Technologies
BioSig Technologies Announces Acceptance of Paper for the 40th International Conference of the IEEE Engineering in Medicine and Biology Society
May 09, 2018 08:00 ET | BioSig Technologies, Inc.
Santa Monica, CA, May 09, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
CPhI_NA_wZones_2019a.png
The Medical Futurist Dr. Bertalan Mesko Unveiled as First Keynote Speaker for CPhI North America 2018
February 06, 2018 08:00 ET | CPhI
NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- CPhI North America, the only event to bring the complete North American pharma supply chain together, today announced that The Medical Futurist Dr....
CURE Logo.png
CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery
January 04, 2018 09:00 ET | CURE Pharmaceutical
OXNARD, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced the launch of their new brand initiative,...